tradingkey.logo
搜索

Cytek Biosciences Inc

CTKB
添加自选
4.590USD
+0.010+0.22%
收盘 07/02, 13:00美东报价延迟15分钟
592.76M总市值
亏损市盈率 TTM

Cytek Biosciences Inc

4.590
+0.010+0.22%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.22%

5天

+2.46%

1月

+6.00%

6月

-6.71%

今年开始到现在

-9.11%

1年

+22.07%

关键数据
4.580今开
4.680最高
889.76K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.69%换手率
4.580昨收
4.535最低
2.79M成交额
亏损市盈率静
1.81市净率
0.00%股息率 TTM
-15.89%ROA
6.18052周最高
0.96量比
-6.02M净利润
129.14M总股本
-0.5786每股收益TTM
1.19Beta
-20.93%ROE
2.46052周最低
3.17%振幅
48.16%毛利率
592.76M总市值
1.65回报/风险
3.50%风险率

TradingKey Cytek Biosciences Inc股票评分

单位: USD 更新时间: 2026-07-02

操作建议

Cytek Biosciences Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名70/204位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价5.69。中期看,股价处于平稳状态。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Cytek Biosciences Inc评分

相关信息

行业排名
70 / 204
全市场排名
171 / 4565
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Cytek Biosciences Inc亮点

亮点风险
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
利润高增长
公司净利润处于行业前列,最新年度总收入201.49M美元
估值高估
公司最新PE估值-7.93,处于3年历史高位
机构减仓
最新机构持股84.13M股,环比减少7.74%
活跃度增加
近期活跃度增加,过去20天平均换手率1.40

分析师目标

根据 4 位分析师
买入
评级
5.688
目标均价
+24.18%
涨幅空间

Cytek Biosciences Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Cytek Biosciences Inc简介

Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
公司代码CTKB
公司Cytek Biosciences Inc
CEOJiang (Wenbin)
网址https://cytekbio.com

常见问题

Cytek Biosciences Inc(CTKB)的当前股价是多少?

Cytek Biosciences Inc(CTKB)的当前股价是 4.59。

Cytek Biosciences Inc的股票代码是什么?

Cytek Biosciences Inc的股票代码是CTKB。

Cytek Biosciences Inc股票的52周最高点是多少?

Cytek Biosciences Inc股票的52周最高点是6.18。

Cytek Biosciences Inc股票的52周最低点是多少?

Cytek Biosciences Inc股票的52周最低点是2.46。

Cytek Biosciences Inc的市值是多少?

Cytek Biosciences Inc的市值是592.76M。

现在Cytek Biosciences Inc(CTKB)的股票是买入、持有还是卖出?

根据分析师评级,Cytek Biosciences Inc(CTKB)的总体评级为买入,目标价格为5.69。

Cytek Biosciences Inc(CTKB)股票的每股收益(EPS TTM)是多少

Cytek Biosciences Inc(CTKB)股票的每股收益(EPS TTM)是-0.52。